Market Overview
The global Surrogacy Market reached a size of USD 204.6 Million in 2025 and is projected to grow to USD 329.2 Million by 2034. It is expected to grow at a CAGR of 5.43% during the forecast period 2026-2034. Market growth is primarily driven by rising infertility prevalence, fertility tourism, convenient and affordable surrogacy options, and favorable governmental payment policies.
Study Assumption Years
- Base Year: 2025
- Historical Years: 2020-2025
- Forecast Period: 2026-2034
Surrogacy Market Key Takeaways
- The global surrogacy market size was USD 204.6 Million in 2025, with a CAGR of 5.43% expected from 2026 to 2034.
- Growth is driven by increasing infertility incidence and heightened societal acceptance of surrogacy.
- Legal reforms in various countries have created transparent and safeguarding regulations, boosting market expansion.
- Advances in IVF treatments have significantly improved surrogacy success rates.
- Increasing demand from LGBTQ+ couples for organic children adds to market growth.
- Economic factors include availability of low-cost surrogacy services across regions.
Sample Request Link: https://www.imarcgroup.com/surrogacy-market/requestsample
Market Growth Factors
Increasing Infertility and Societal Awareness
The surrogacy market has developed from a combination of increased infertility around the world, increased awareness of surrogacy as a reproductive option and legal developments which have made commercial surrogacy safer and more open for those involved. In addition, the surrogacy services may be available at lower rates and thus may be affordable to larger sections of the population.
Legal Framework and Support
The legislative environment impacts the surrogacy market, with risks being reduced in jurisdictions with clear and supportive laws which provide a safe and trusted environment for surrogates and IPs. Around 90% of surrogacy arrangements are gestational surrogacy and issues of parental rights and custody have been addressed. Gestational surrogacy has estimated success rates of up to 75% due in part to advances in in vitro fertilization and legal protection.
Advancements in Reproductive Technologies
With technology such as IVF, genetic testing and embryo transfer, pregnancy rates per embryo transfer in gestational surrogacy are now estimated at between 30% and 60% depending on age and physical condition of the surrogate candidate. 2% of babies born in the United States are the result of assisted reproductive technologies, making surrogacy a much safer and appealing option for would-be parents than it has been.
Market Segmentation
Breakup by Type:
- Gestational Surrogacy: Dominates the market, involving surrogates carrying pregnancies conceived from intended parents’ or donors’ eggs and sperm. It reduces genetic connection to the surrogate, minimizing legal and psychological challenges, and benefits diverse populations including same-sex couples.
- Traditional Surrogacy
Breakup by Technology:
- IVF with ICSI: Holds the largest market share due to addressing male infertility by injecting a single sperm directly into an egg, maximizing fertilization and broadening surrogacy applicability.
- IVF without ICSI
- Intrauterine Insemination
Breakup by Service Provider:
- Fertility Clinics: Represent the largest share, providing advanced reproductive technologies, full medical assessments, and close coordination with legal and surrogacy agencies to ensure successful pregnancies.
- Hospitals
- Others
Breakup by Region:
- North America: The dominant regional market, benefiting from supportive legal frameworks, advanced medical facilities, and high societal acceptance attracting domestic and international surrogacy clients.
- Asia-Pacific
- Europe
- Latin America
- Middle East and Africa
Regional Insights
North America dominates the global surrogacy market owing to a legally favorable environment protecting all parties’ rights, advanced fertility treatment centers, and high public acceptance. The region attracts both domestic and international intended parents seeking reliable services. These factors collectively make North America the leading market globally.
Recent Developments & News
- In June 2021, Circle Surrogacy & Egg Donation launched the “A Lifetime of Pride and Joy” campaign promoting family equality and accessible fertility care for the LGBTQ+ population.
- In June 2023, Nova IVF Fertility announced plans to expand to 100 centers across India within four years, enhancing accessible advanced fertility care.
- In October 2022, Ovation Fertility partnered with Genomic Prediction to advance genetic testing within fertility and family planning, offering deeper genetic insights to intended parents.
Key Players
- Bourn Hall Fertility Clinic
- Care Fertility
- Circle Surrogacy
- Extraordinary Conceptions
- Growing Generations
- Houston Fertility Center
- IVIRMA Global
- Kindbody
- Max Healthcare
- New Hope Fertility Clinic
- Nova IVF
- Ovation Fertility
Customization Note
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
Request For Customization:
https://www.imarcgroup.com/request?type=report&id=5298&flag=E
About Us
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
Contact Us
IMARC Group,
134 N 4th St. Brooklyn, NY 11249, USA,
Email: sales@imarcgroup.com,
Tel No: (D) +91 120 433 0800,
United States: +1-201971-6302
